According to a report, 16 new GLP-1-based weight loss drugs could be launched on the market by 2029 (NYSE:NVO)
Sep. 10, 2024, 6:56 pm Eastern TimeNovo Nordisk A/S (NVO) shares, LLY sharesAMGN, JNJ, RHHBYPFE, MRK, AZN, VKTX, GPCRBy: Val ...
Tag: GLP1based
Recommended.
